On 2025-05-08, Cytek Biosciences, Inc. (CTKB) announced earnings per share of $-0.09 for the fiscal quarter ending 2025-03-31, missing the average analyst estimate of $-0.04.
The next expected annoucement date for quarterly earnings is 2025-08-05, with an average estimated earnings per share of $-0.07 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-05-08 | 2025-03-31 | $-0.04 | $-0.09 |
| 2025-02-27 | 2024-12-31 | $0.06 | $0.07 |
| 2024-11-05 | 2024-09-30 | $-0.02 | $0.01 |
| 2024-08-06 | 2024-06-30 | $-0.03 | $-0.08 |
| 2024-05-08 | 2024-03-31 | $-0.05 | $-0.05 |
| 2024-03-13 | 2023-12-31 | -- | $0.04 |
| 2023-11-07 | 2023-09-30 | $-0.01 | $-0.03 |
| 2023-08-08 | 2023-06-30 | $0.00 | $-0.02 |
| 2023-05-09 | 2023-03-31 | $0.00 | $-0.03 |
| 2023-02-28 | 2022-12-31 | $0.02 | $0.03 |
| 2022-11-09 | 2022-09-30 | $0.02 | $0.01 |
| 2022-08-10 | 2022-06-30 | $0.02 | $0.00 |
| 2022-05-11 | 2022-03-31 | $0.01 | $-0.02 |
| 2022-02-23 | 2021-12-31 | -- | $0.05 |
| 2021-11-08 | 2021-09-30 | $0.00 | $0.00 |
| 2021-09-02 | 2021-06-30 | $0.03 | $0.00 |